Keywords: ph, iii, xarelto, data, presented, ash, bayer

PH III Xarelto data to be presented at ASH

Article | 19 November 2007

Print This

Bayer HealthCare, part of Germany's Bayer Group, has announced plans to present data from a Phase III trial of its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in